Raymond James & Associates’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-11,565
| Closed | -$317K | – | 3914 |
|
|
2022
Q2 | $317K | Sell |
11,565
-551
| -5% | -$15.1K | ﹤0.01% | 3181 |
|
|
2022
Q1 | $457K | Buy |
12,116
+2,111
| +21% | +$79.6K | ﹤0.01% | 3105 |
|
|
2021
Q4 | $621K | Buy |
10,005
+508
| +5% | +$31.5K | ﹤0.01% | 2922 |
|
|
2021
Q3 | $812K | Sell |
9,497
-3,540
| -27% | -$303K | ﹤0.01% | 2713 |
|
|
2021
Q2 | $807K | Sell |
13,037
-72
| -0.5% | -$4.46K | ﹤0.01% | 2727 |
|
|
2021
Q1 | $639K | Buy |
13,109
+3,085
| +31% | +$150K | ﹤0.01% | 2817 |
|
|
2020
Q4 | $312K | Sell |
10,024
-740
| -7% | -$23K | ﹤0.01% | 3080 |
|
|
2020
Q3 | $224K | Buy |
+10,764
| New | +$224K | ﹤0.01% | 3116 |
|